BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

MdBio, Inc. Breakfast Leadership Series to Explore Rising Tide of Non-Traditional Funding Opportunities for Bringing New Drugs to Market


2/27/2013 10:44:29 AM

ROCKVILLE, MD--(Marketwire - February 27, 2013) -


WHO:
Tech Council of Maryland

WHAT:
"The Rising Tide of Non-Traditional Funding Opportunities"
MdBio Breakfast Leadership Series

WHERE:
Bethesda Country Club
7601 Bradley Blvd
Bethesda, MD 20817

WHEN:
Thursday, March 14
8 a.m. - 10 a.m.

WHY:
For the latest event in its Breakfast Leadership Series, TCM's MdBio Division is bringing together executives of advocacy organizations and drug manufacturers who are taking a venture philanthropy approach to bringing new, promising disease-specific drugs to market.

Advocacy groups and individuals seeking cures to various diseases are now playing an active role in funding research and development and commercialization of new drugs, including orphan drugs for rare conditions that typically do not get broad attention in today's competitive market.

This venture philanthropy approach is having a significant impact, including the January 2012 approval of Kalydeco, a new oral medication that targets the underlying cause of cystic fibrosis -- a faulty gene and its protein product, CFTR. Kalydeco was brought to market through a partnership between the Cystic Fibrosis Foundation (CFF) and drugmaker Vertex Pharmaceuticals, Inc.

Other organizations, such as FasterCures and the Parkinson's Action Network, are taking a similar approach to changing the medical research ecosystems by directing funding toward development of promising drugs for specific diseases vs. general, unproven technologies.

During this Breakfast Leadership Series, attendees will:

  • Hear about how CFF and Vertex have worked together on their target (approved) drug and what you should know about this experience.
  • Learn about what FasterCures does, and the importance of their advocacy role in moving research to patients/products.
  • Find out more about the Parkinson's Action Network, what funding it has available and how companies can partner with the group.

SPEAKERS:
Panelists include:

  • Margaret Anderson, Executive Director, FasterCures
  • Amy Comstock Rick, J.D., CEO, Parkinson's Action Network
  • Mary B. Dwight, Vice President of Government Affairs, Cystic Fibrosis Foundation
  • Samantha C. Ventimiglia, Senior Director, Government Affairs and Public Policy, Vertex Pharmaceuticals, Inc.

ATTEND:
To register or for more information, please visit the TCM website.

ABOUT THE TECH COUNCIL OF MARYLAND, INC.
The Tech Council of Maryland (TCM) is the largest technology trade group serving the advanced technology and biotechnology communities of Maryland. TCM's mission is to advocate for the interests of the technology community, further the role of technology in the Maryland economy, and nurture an environment where technology companies can collaborate, grow and succeed. For more information, visit www.techcouncilmd.com.


CONTACT:
Brad Wills
Wills & Associates Public Relations
240.752.7171
Email Contact

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES